Skip To Main Content

Koulutusvideot

Järjestä

Suodattimet

Nollaa
  • Terapia-alue

Personalized approach in T2D is key for success

The Sanofi webinar ‘Act Now for Impact: Glycemic Control and Beyond’ focuses on recent advancements in treating type 2 diabetes (T2D), emphasizing a personalized approach for better outcomes. Prof. Frank Nobels (Belgium), prof. De Galan (the Netherlands) and Prof Björn Eliasson (Sweden) addressed various aspects of T2D treatment in the present era.

EADV24 Highlights

A phase III randomized trial evaluating alirocumab 300 mg every 4 weeks as monotherapy or add-on to statin: ODYSSEY CHOICE I

Roth Eli M et al. Atherosclerosis vol. 254 (2016): 254-262

Videotallenne: Beyfortus® -valmisteen oikea ja turvallinen käyttö

Introduction to hand and foot dermatitis

Hot topics in atopic dermatitis: Hear it from the experts

DERM 360° 6.11

Long-term control in AD with Professor Diamant Thaci

Webinaarisarja rabieksesta 2/2: Rabiesrokotukset

Why Don’t We Strike Early, Strike Strong?

Prof. Dr. Halvorsen, Prof. Dr. Sinnaeve & Prof. Dr. Martens

NLC 2024 | Sanofi & Sinä

COPD Research Forum

Videotallenne: Tietoa hoitajille vauvojen RSV-infektioiden ehkäisystä